Disruption of nongenomic testosterone signaling in a model of spinal and bulbar muscular atrophy

Molecular Endocrinology

Volumn 26, Issue 7, 2012, Pages 1102-1116

  Schindler, Mathilde ^a,b   Fabre, Christine ^a,b   de Weille, Jan ^a   Carreau, Serge ^c   Mersel, Marcel ^a   Bakalara, Norbert ^a,b  

^a Montpellier University Medical Center   (France)

^b INSTITUT CHARLES GERHARDT   (France)

^c UNIVERSITÉ DE CAEN   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR; ANDROGEN RECEPTOR 20Q; ANDROGEN RECEPTOR 51Q; GLYCOGEN SYNTHASE KINASE 3ALPHA; LACTATE DEHYDROGENASE; PHOSPHATIDYLINOSITOL 3 KINASE; STRESS ACTIVATED PROTEIN KINASE; TESTOSTERONE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL LEVEL; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; EMBRYO; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; GAIN OF FUNCTION MUTATION; GENE DELETION; IN VITRO STUDY; INTRACELLULAR SIGNALING; KENNEDY DISEASE; LOSS OF FUNCTION MUTATION; MOLECULAR MECHANICS; MOTONEURON; MOUSE; NERVE CELL DIFFERENTIATION; NERVE FIBER GROWTH; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; CELL LINE; GLYCOGEN SYNTHASE KINASE 3; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MEMBRANE MICRODOMAINS; MICE; MICE, TRANSGENIC; MOTOR NEURONS; MUSCULAR DISORDERS, ATROPHIC; PEPTIDES; PHOSPHATIDYLINOSITOL 3-KINASE; PHOSPHORYLATION; RECEPTORS, ANDROGEN; SIGNAL TRANSDUCTION; TESTOSTERONE;

EID: 84863327666     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2011-1367     Document Type: Article

References (71)

1. Zoghbi HY, Orr HT 2000 Glutamine repeats and neurodegenera-tion. Annu Rev Neurosci 23:217-247
2. Kennedy WR, Alter M, Sung JH 1968 Progressive proximal spinal and bulbar muscular atrophy of late onset. A sex-linked recessive trait. Neurology 18:671-680
3. La Spada AR, Wilson EM, Lubahn DB, Harding AE, Fischbeck KH 1991 Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy. Nature 352:77-79
4. Li M, Miwa S, Kobayashi Y, Merry DE, Yamamoto M, Tanaka F, Doyu M, Hashizume Y, Fischbeck KH, Sobue G 1998 Nuclear inclusions of the androgen receptor protein in spinal and bulbar muscular atrophy. Ann Neurol 44:249-254
5. McCampbell A, Taylor JP, Taye AA, Robitschek J, Li M, Walcott J, Merry D, Chai Y, Paulson H, Sobue G, Fischbeck KH 2000 CREB-binding protein sequestration by expanded polyglutamine. Hum Mol Genet 9:2197-2202
6. Cummings CJ, Mancini MA, Antalffy B, DeFranco DB, Orr HT, Zoghbi HY 1998 Chaperone suppression of aggregation and altered subcellular proteasome localization imply protein misfolding in SCA1. Nat Genet 19:148-154
7. Stenoien DL, Cummings CJ, Adams HP, Mancini MG, Patel K, DeMartino GN, Marcelli M, Weigel NL, Mancini MA 1999 Poly-glutamine-expanded androgen receptors form aggregates that sequester heat shock proteins, proteasome components and SRC-1, and are suppressed by the HDJ-2 chaperone. Hum Mol Genet 8:731-741
8. Paulson HL 1999 Protein fate in neurodegenerative proteinopa-thies: polyglutamine diseases join the (mis)fold. Am J Hum Genet 64:339-345
9. Klement IA, Skinner PJ, Kaytor MD, Yi H, Hersch SM, Clark HB, Zoghbi HY, Orr HT 1998 Ataxin-1 nuclear localization and aggregation: role in polyglutamine-induced disease in SCA1 transgenic mice. Cell 95:41-53
10. Arrasate M, Mitra S, Schweitzer ES, Segal MR, Finkbeiner S 2004 Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death. Nature 431:805-810
11. Li M, Chevalier-Larsen ES, Merry DE, Diamond MI 2007 Soluble androgen receptor oligomers underlie pathology in a mouse model of spinobulbar muscular atrophy. J Biol Chem 282:3157-3164
12. Takahashi T, Kikuchi S, Katada S, Nagai Y, Nishizawa M, On-odera O 2008 Soluble polyglutamine oligomers formed prior to inclusion body formation are cytotoxic. Hum Mol Genet 17:345-356
13. Novitskaya V, Bocharova OV, Bronstein I, Baskakov IV 2006 Amyloid fibrils of mammalian prion protein are highly toxic to cultured cells and primary neurons. J Biol Chem 281:13828-13836
14. Simeoni S, Mancini MA, Stenoien DL, Marcelli M, Weigel NL, Zanisi M, Martini L, Poletti A 2000 Motoneuronal cell death is not correlated with aggregate formation of androgen receptors containing an elongated polyglutamine tract. Hum Mol Genet 9:133-144
15. Thomas Jr PS, Fraley GS, Damian V, Damien V, Woodke LB, Zapata F, Sopher BL, Plymate SR, La Spada AR 2006 Loss of endogenous androgen receptor protein accelerates motor neuron degeneration and accentuates androgen insensitivity in a mouse model of X-linked spinal and bulbar muscular atrophy. Hum Mol Genet 15:2225-2238
16. Lund A, Udd B, Juvonen V, Andersen PM, Cederquist K, Davis M, Gellera C, Kölmel C, Ronnevi LO, Sperfeld AD, Sörensen SA, Tranebjaerg L, Van Maldergem L, Watanabe M, Weber M, Yeung L, Savontaus ML 2001 Multiple founder effects in spinal and bul-bar muscular atrophy (SBMA, Kennedy disease) around the world. Eur J Hum Genet 9:431-436
17. Schengrund CL 2010 Lipid rafts: keys to neurodegeneration. Brain Res Bull 82:7-17
18. Pedram A, Razandi M, Sainson RC, Kim JK, Hughes CC, Levin ER 2007 A conserved mechanism for steroid receptor translocation to the plasma membrane. J Biol Chem 282:22278-22288
19. Hatzoglou A, Kampa M, Kogia C, Charalampopoulos I, Theodoro-poulos PA, Anezinis P, Dambaki C, Papakonstanti EA, Stathopou-los EN, Stournaras C, Gravanis A, Castanas E 2005 Membrane androgen receptor activation induces apoptotic regression of human prostate cancer cells in vitro and in vivo. J Clin Endocrinol Metab 90:893-903
20. Kampa M, Kogia C, Theodoropoulos PA, Anezinis P, Charalampopoulos I, Papakonstanti EA, Stathopoulos EN, Hatzoglou A, Stournaras C, Gravanis A, Castanas E 2006 Activation of membrane androgen receptors potentiates the antiproliferative effects of paclitaxel on human prostate cancer cells. Mol Cancer Ther 5:1342-1351
21. Benten WP, Lieberherr M, Stamm O, Wrehlke C, Guo Z, Wunder-lich F 1999 Testosterone signaling through internalizable surface receptors in androgen receptor-free macrophages. Mol Biol Cell 10:3113-3123
22. Benten WP, Lieberherr M, Giese G, Wrehlke C, Stamm O, Sekeris CE, Mossmann H, Wunderlich F 1999 Functional testosterone receptors in plasma membranes of T cells. FASEB J 13:123-133
23. Fix C, Jordan C, Cano P, Walker WH 2004 Testosterone activates mitogen-activated protein kinase and the cAMP response element binding protein transcription factor in Sertoli cells. Proc Natl Acad Sci USA 101:10919-10924
24. Gatson JW, Kaur P, Singh M 2006 Dihydrotestosterone differentially modulates the mitogen-activated protein kinase and the phos-phoinositide 3-kinase/Akt pathways through the nuclear and novel membrane androgen receptor in C6 cells. Endocrinology 147: 2028-2034
25. Gatson JW, Singh M 2007 Activation of a membrane-associated androgen receptor promotes cell death in primary cortical astrocytes. Endocrinology 148:2458-2464
26. Cheng J, Watkins SC, Walker WH 2007 Testosterone activates mitogen-activated protein kinase via Src kinase and the epidermal growth factor receptor in Sertoli cells. Endocrinology 148:2066-2074
27. Cinar B, Mukhopadhyay NK, Meng G, Freeman MR 2007 Phos-phoinositide 3-kinase-independent non-genomic signals transit from the androgen receptor to Akt1 in membrane raft microdo-mains. J Biol Chem 282:29584-29593
28. Kazemi-Esfarjani P, Trifiro MA, Pinsky L 1995 Evidence for a repressive function of the long polyglutamine tract in the human androgen receptor: possible pathogenetic relevance for the (CAG)n-expanded neuronopathies. Hum Mol Genet 4:523-527
29. Lieberman AP, Harmison G, Strand AD, Olson JM, Fischbeck KH 2002 Altered transcriptional regulation in cells expressing the expanded polyglutamine androgen receptor. Hum Mol Genet 11: 1967-1976
30. Cashman NR, Durham HD, Blusztajn JK, Oda K, Tabira T, Shaw IT, Dahrouge S, Antel JP 1992 Neuroblastoma X spinal cord (NSC) hybrid cell lines resemble developing motor neurons. Dev Dyn 194: 209-221
31. Giovannucci E, Stampfer MJ, Krithivas K, Brown M, Dahl D, Bruf-sky A, Talcott J, Hennekens CH, Kantoff PW 1997 The CAG repeat within the androgen receptor gene and its relationship to prostate cancer. Proc Natl Acad Sci USA 94:3320-3323
32. Giovannucci E 2002 Is the androgen receptor CAG repeat length significant for prostate cancer? Cancer Epidemiol Biomarkers Prev 11:985-986
33. Herdegen T, Waetzig V 2001 AP-1 proteins in the adult brain: facts and fiction about effectors of neuroprotection and neurodegenera-tion. Oncogene 20:2424-2437
34. Lindwall C, Dahlin L, Lundborg G, Kanje M 2004 Inhibition of c-Jun phosphorylation reduces axonal outgrowth of adult rat nodose ganglia and dorsal root ganglia sensory neurons. Mol Cell Neurosci 27:267-279
35. Raivich G, Bohatschek M, Da Costa C, Iwata O, Galiano M, Hris-tova M, Nateri AS, Makwana M, Riera-Sans L, Wolfer DP, Lipp HP, Aguzzi A, Wagner EF, Behrens A 2004 The AP-1 transcription factor c-Jun is required for efficient axonal regeneration. Neuron 43:57-67
36. Rakotoarivelo C, Petite D, de Weille J, Lumbroso S, Privat A, Sultan C, Mersel M 2007 Mild surfection of neural cells, especially mo-toneurons, in primary culture and cell lines. Exp Neurol 204:118- 130
37. Macdonald JL, Pike LJ 2005 A simplified method for the preparation of detergent-free lipid rafts. J Lipid Res 46:1061-1067
38. Fargo KN, Galbiati M, Foecking EM, Poletti A, Jones KJ 2008 Androgen regulation of axon growth and neurite extension in mo-toneurons. Horm Behav 53:716-728
39. Mayor S, Maxfield FR 1995 Insolubility and redistribution of GPI-anchored proteins at the cell surface after detergent treatment. Mol Biol Cell 6:929-944
40. Ross CA, Poirier MA 2004 Protein aggregation and neurodegen-erative disease. Nat Med 10(Suppl):S10-S17
41. Gatchel JR, Zoghbi HY 2005 Diseases of unstable repeat expansion: mechanisms and common principles. Nat Rev Genet 6:743-755
42. Merry DE, Kobayashi Y, Bailey CK, Taye AA, Fischbeck KH 1998 Cleavage, aggregation and toxicity of the expanded androgen receptor in spinal and bulbar muscular atrophy. Hum Mol Genet 7:693-701
43. Kobayashi Y, Kume A, Li M, Doyu M, Hata M, Ohtsuka K, Sobue G 2000 Chaperones Hsp70 and Hsp40 suppress aggregate formation and apoptosis in cultured neuronal cells expressing truncated androgen receptor protein with expanded polyglutamine tract. J Biol Chem 275:8772-8778
44. Brooks BP, Merry DE, Paulson HL, Lieberman AP, Kolson DL, Fischbeck KH 1998 A cell culture model for androgen effects in motor neurons. J Neurochem 70:1054-1060
45. Marron TU, Guerini V, Rusmini P, Sau D, Brevini TA, Martini L, Poletti A 2005 Androgen-induced neurite outgrowth is mediated by neuritin in motor neurones. J Neurochem 92:10-20
46. Butler R, Leigh PN, Gallo JM 2001 Androgen-induced up-regula-tion of tubulin isoforms in neuroblastoma cells. J Neurochem 78: 854-861
47. Avila DM, Allman DR, Gallo JM, McPhaul MJ 2003 Androgen receptors containing expanded polyglutamine tracts exhibit progressive toxicity when stably expressed in the neuroblastoma cell line, SH-SY 5Y. Exp Biol Med (Maywood) 228:982-990
48. DiFiglia M, Sapp E, Chase KO, Davies SW, Bates GP, Vonsattel JP, Aronin N 1997 Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science 277:1990-1993
49. Cooper MK, Porter JA, Young KE, Beachy PA 1998 Teratogen-mediated inhibition of target tissue response to Shh signaling. Science 280:1603-1607
50. Michels G, Hoppe UC 2008 Rapid actions of androgens. Front Neuroendocrinol 29:182-198
51. Lu ML, Schneider MC, Zheng Y, Zhang X, Richie JP 2001 Caveo-lin-1 interacts with androgen receptor. A positive modulator of androgen receptor mediated transactivation. J Biol Chem 276: 13442-13451
52. Kim SB, Kanno A, Ozawa T, Tao H, Umezawa Y 2007 Non-genomic activity of ligands in the association of androgen receptor with SRC. ACS Chem Biol 2:484-492
53. Kousteni S, Bellido T, Plotkin LI, O'Brien CA, Bodenner DL, Han L, Han K, DiGregorio GB, Katzenellenbogen JA, Katzenellenbogen BS, Roberson PK, Weinstein RS, Jilka RL, Manolagas SC 2001 Nongenotropic, sex-nonspecific signaling through the estrogen or androgen receptors: dissociation from transcriptional activity. Cell 104:719-730
54. Migliaccio A, Castoria G, Di Domenico M, de Falco A, Bilancio A, Lombardi M, Barone MV, Ametrano D, Zannini MS, Abbondanza C, Auricchio F 2000 Steroid-induced androgen receptor-oestradiol receptor beta-Src complex triggers prostate cancer cell proliferation. EMBO J 19:5406-5417
55. Das M, Scappini E, Martin NP, Wong KA, Dunn S, Chen YJ, Miller SL, Domin J, O'Bryan JP 2007 Regulation of neuron survival through an intersectin-phosphoinositide 3'-kinase C2beta-AKT pathway. Mol Cell Biol 27:7906-7917
56. Yu F, Sugawara T, Maier CM, Hsieh LB, Chan PH 2005 Akt/Bad signaling and motor neuron survival after spinal cord injury. Neu-robiol Dis 20:491-499
57. Georget V, Lobaccaro JM, Terouanne B, Mangeat P, Nicolas JC, Sultan C 1997 Trafficking of the androgen receptor in living cells with fused green fluorescent protein-androgen receptor. Mol Cell Endocrinol 129:17-26
58. Schaufele F, Carbonell X, Guerbadot M, Borngraeber S, Chapman MS, Ma AA, Miner JN, Diamond MI 2005 The structural basis of androgen receptor activation: intramolecular and intermolecular amino-carboxy interactions. Proc Natl Acad Sci USA 102:9802-9807
59. Waetzig V, Zhao Y, Herdegen T 2006 The bright side of JNKs-Multitalented mediators in neuronal sprouting, brain development and nerve fiber regeneration. Prog Neurobiol 80:84-97
60. Barnat M, Enslen H, Propst F, Davis RJ, Soares S, Nothias F 2010 Distinct roles of c-Jun N-terminal kinase isoforms in neurite initiation and elongation during axonal regeneration. J Neurosci 30: 7804-7816
61. Chaves CS, Soares DC, Da Silva RP, Saraiva EM 2003 Characterization of the species- and stage-specificity of two monoclonal antibodies against Leishmania amazonensis. Exp Parasitol 103:152-159
62. Frame S, Cohen P 2001 GSK3 takes centre stage more than 20 years after its discovery. Biochem J 359:1-16
63. Palazzolo I, Burnett BG, Young JE, Brenne PL, La Spada AR, Fis-chbeck KH, Howell BW, Pennuto M 2007 Akt blocks ligand binding and protects against expanded polyglutamine androgen receptor toxicity. Hum Mol Genet 16:1593-1603
64. Wei W, Jin J, Schlisio S, Harper JW, Kaelin Jr WG 2005 The v-Jun point mutation allows c-Jun to escape GSK3-dependent recognition and destruction by the Fbw7 ubiquitin ligase. Cancer Cell 8:25-33
65. Morton S, Davis RJ, McLaren A, Cohen P 2003 A reinvestigation of the multisite phosphorylation of the transcription factor c-Jun. EMBO J 22:3876-3886
66. Katsuno M, Adachi H, Waza M, Banno H, Suzuki K, Tanaka F, Doyu M, Sobue G 2006 Pathogenesis, animal models and therapeutics in spinal and bulbar muscular atrophy (SBMA). Exp Neurol 200:8-18
67. Katsuno M, Adachi H, Doyu M, Minamiyama M, Sang C, Ko-bayashi Y, Inukai A, Sobue G 2003 Leuprorelin rescues polyglu-tamine-dependent phenotypes in a transgenic mouse model of spinal and bulbar muscular atrophy. Nat Med 9:768-773
68. Dehm SM, Tindall DJ 2006 Ligand-independent androgen receptor activity is activation function-2-independent and resistant to anti-androgens in androgen refractory prostate cancer cells. J Biol Chem 281:27882-27893
69. Feldman BJ, Feldman D 2001 The development of androgen-inde-pendent prostate cancer. Nature reviews 1:34-45
70. Estrada M, Espinosa A, Müller M, Jaimovich E 2003 Testosterone stimulates intracellular calcium release and mitogen-activated protein kinases via a G protein-coupled receptor in skeletal muscle cells. Endocrinology 144:3586-3597
71. Lieberherr M, Grosse B 1994 Androgens increase intracellular calcium concentration and inositol 1,4,5-trisphosphate and diacyl-glycerol formation via a pertussis toxin-sensitive G-protein. J Biol Chem 269:7217-7223